Skip to main content

and
  1. No Access

    Article

    Radiomics predicts risk of cachexia in advanced NSCLC patients treated with immune checkpoint inhibitors

    Approximately 50% of cancer patients eventually develop a syndrome of prolonged weight loss (cachexia), which may contribute to primary resistance to immune checkpoint inhibitors (ICI). This study utilised rad...

    Wei Mu, Evangelia Katsoulakis, Christopher J. Whelan in British Journal of Cancer (2021)